Fudan University Cancer Hospital
Fudan University Cancer Hospital
Shanghai, Shanghai Municipality, China5 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 3 | 2026-09-04 | NCT04821622 | |
| Ivonescimab in the Treatment of Multiple Advanced Tumors | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Myosarcoma, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Adipose Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Ductal, Lobular, and Medullary, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, angiomyolipoma, basal cell carcinoma, basal cell neoplasm, benign urinary system neoplasm, bladder urachal carcinoma, carcinoma, epithelial neoplasm, extramammary Paget disease, kidney angiomyolipoma, kidney cancer, kidney disorder, male reproductive organ cancer, male reproductive system disorder, myomatous neoplasm, neoplasm, neoplasm with perivascular epithelioid cell differentiation, neuroendocrine carcinoma, neuroendocrine neoplasm, paraganglioma, penile cancer, penile disorder, penile neoplasm, pheochromocytoma, pheochromocytoma-paraganglioma, primitive neuroectodermal tumor, prostate cancer, prostate disorder, rhabdomyosarcoma, sarcoma, sarcomatoid carcinoma, transitional cell carcinoma, urinary system disorder, urothelial carcinoma | Recruiting | Phase 2 | 2025-08-24 | NCT06683846 | |
| Comparing the Efficacy of Sintilimab Plus Nab-POF Regimen, Sintilimab Plus XELOX Chemotherapy, and Lenvatinib, Sintilimab Plus XELOX Chemotherapy in the Treatment of HER2-negative, Metastatic Gastric Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric neoplasm, neoplasm, stomach disorder | Not yet recruiting | Phase 2 | 2024-12-27 | NCT06748508 | |
| Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors | Genital Diseases, Male Urogenital Diseases, Myosarcoma, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Neoplasms, Ductal, Lobular, and Medullary, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, bladder urachal carcinoma, carcinoma, endocrine system disorder, epithelial neoplasm, extramammary Paget disease, gonadal disorder, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, myomatous neoplasm, neoplasm, penile cancer, penile disorder, penile neoplasm, rhabdomyosarcoma, sarcoma, testicular cancer, testicular disorder | Recruiting | Phase 2 | 2024-12-20 | NCT06684327 | |
| A Study of HS-20089 in Patients With Advanced Solid Tumors | Advanced Solid Tumor | Recruiting | Phase 1 | 2024-04-03 | NCT05263479 |